Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Reduction in environmental pollution and emissions as waste is reused
Material for insulation purposes
High durability
Easy to store and transport
Simple and low-cost technique
More than 14 communities and 128 families participated
1,725 eco-bricks were recollected
8,000 USD in vouchers for supermarkets were distributed to the families who participated – a huge relief in COVID times
110,350 m2 of waste was recycled
More than 110,350 m2 of constructions will be built
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Rationalising the use of energy and natural resources and act on the processes in order to optimise and reduceconsumption.
Reducing the production of waste by increasing and promoting recycling and recovering material wheneverpossible.
Ensuring that materials and procedures used don’t present any risk to the health of workers and to the environment.
Making sure that the use of materials, resources and the incorporation of safe and innovative technologies promoteenvironmental protection and minimise the environmental impacts.
Coaching and engaging employees to perform in a conscious and responsible manner, for the importance ofeveryone in guaranteeing product safety and for improving environmental performance.
Implementing good practices in order to comply with applicable legislation and other requirements that will leadto the environmental preservation.
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
In accordance with California Act Assembly Bill 906 and ASTM D7611/D7611M - Standard Practice for Coding Plastic Manufactured Articles for Resin Identification. Products comply with the compositional requirements of the Food and Drug Administration (FDA) regulation and European Regulation 10/2011.
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Reassure consumers & provide trust to end-users (B2C), increasing public interest in recyclability and recycled content
Demonstrate compliance with legislation (B2B) & verify claims via third-party assessments
Show transparency about recyclability and waste origin and source
Support corporate sustainability claims about recycled content and recyclability of plastics
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Excellent chemical resistance
Good barrier properties
Exceptional clarity
High brightness
Design flexibility
Easy to process
Excellent decorative ability
Processing flexibility
Fast cycle times
High impact resistance
Heavy wall capacity
Ease of secondary operations
Free of BPA and additives
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
The UPM life cycle assessment was carried out in accordance with ISO 14040 and based on cradle-to-gate systemboundary. As the biorefinery is currently in the process of being built, the LCA will be gradually updated with primary data.The study has been critically reviewed by an independent third party according to ISO 14044.
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Clermont-Ferrand (France), Tuesday 24th September 2024. - CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and SELENIS, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1. By leveraging CARBIOS’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."